Insider Transactions in Q3 2022 at Athenex, Inc. (ATNX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
47,303
+1.28%
|
$0
$0.24 P/Share
|
|
Sep 23
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,333
+5.62%
|
$0
$0.24 P/Share
|
|
Sep 23
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,075
+11.49%
|
$0
$0.24 P/Share
|
|
Sep 16
2022
|
Timothy De Vere Cook Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
548
-3.79%
|
$0
$0.41 P/Share
|
|
Sep 16
2022
|
Timothy De Vere Cook Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+13.46%
|
-
|
|
Sep 16
2022
|
Daniel Lang Pres Cell Therapy, VP Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
4,323
-5.03%
|
$0
$0.41 P/Share
|
|
Sep 16
2022
|
Daniel Lang Pres Cell Therapy, VP Corp Dev |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+12.7%
|
-
|
|
Sep 09
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,079
+8.12%
|
$0
$0.46 P/Share
|
|
Sep 09
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,572
+3.18%
|
$0
$0.46 P/Share
|
|
Sep 09
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
24,596
+0.68%
|
$0
$0.46 P/Share
|
|
Aug 26
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,056
+8.66%
|
$0
$0.47 P/Share
|
|
Aug 26
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,346
+3.22%
|
$0
$0.47 P/Share
|
|
Aug 26
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
24,071
+0.67%
|
$0
$0.47 P/Share
|
|
Aug 22
2022
|
Jinn Wu Director |
BUY
Open market or private purchase
|
Direct |
10,000
+2.02%
|
$0
$0.42 P/Share
|
|
Aug 19
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
20,000
+0.56%
|
$0
$0.45 P/Share
|
|
Aug 12
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
961
+8.7%
|
$0
$0.52 P/Share
|
|
Aug 12
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
21,923
+0.62%
|
$0
$0.52 P/Share
|
|
Aug 12
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,423
+3.04%
|
$0
$0.52 P/Share
|
|
Aug 03
2022
|
John Vierling Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+17.51%
|
-
|
|
Aug 03
2022
|
Benson Kwan Hung Tsang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+15.98%
|
-
|
|
Aug 03
2022
|
Robert J. Spiegel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+33.66%
|
-
|
|
Aug 03
2022
|
Jordan Kanfer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+30.51%
|
-
|
|
Aug 03
2022
|
Manson Fok Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+0.31%
|
-
|
|
Aug 03
2022
|
Stephanie A Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+17.17%
|
-
|
|
Aug 03
2022
|
Jinn Wu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+1.56%
|
-
|
|
Aug 03
2022
|
Jeffrey Yordon Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,663
-1.47%
|
$0
$0.58 P/Share
|
|
Aug 03
2022
|
Jeffrey Yordon Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+4.77%
|
-
|
|
Aug 03
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
9,132
-0.26%
|
$0
$0.58 P/Share
|
|
Aug 03
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+1.05%
|
-
|
|
Aug 03
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,262
-1.44%
|
$0
$0.58 P/Share
|
|
Aug 03
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+5.59%
|
-
|
|
Jul 29
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
986
+9.76%
|
$0
$0.51 P/Share
|
|
Jul 29
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
22,485
+0.64%
|
$0
$0.51 P/Share
|
|
Jul 20
2022
|
Jinn Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,772
+2.66%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
John Vierling Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,772
+31.46%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
Robert J. Spiegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,508
+34.66%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
Manson Fok Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,270
+0.55%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
Stephanie A Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,138
+17.58%
|
$0
$0.67 P/Share
|
|
Jul 20
2022
|
Benson Kwan Hung Tsang Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,280
+28.87%
|
$0
$0.67 P/Share
|
|
Jul 15
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
843
+9.39%
|
$0
$0.59 P/Share
|
|
Jul 15
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,256
+2.99%
|
$0
$0.59 P/Share
|
|
Jul 15
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
19,208
+0.55%
|
$0
$0.59 P/Share
|
|
Jul 09
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,665
+3.36%
|
$0
$0.51 P/Share
|
|
Jul 01
2022
|
Timothy De Vere Cook Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,154
+13.67%
|
$0
$0.43 P/Share
|
|
Jul 01
2022
|
Rudolf Kwan EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,316
+4.17%
|
$0
$0.43 P/Share
|
|
Jul 01
2022
|
Johnson Yiu Nam Lau CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
26,328
+0.76%
|
$0
$0.43 P/Share
|